Quick Search 
Drugs of the Future
Register or sign in

  
 
  
Volume 36, Issue 3, March 2011, Pages 175-263
 
MONOGRAPHS
 
  
 Ganitumab.
Human anti-CD221 (IGF-IR) monoclonal antibody.
Cole, P.
Drugs Fut 2011, 36(3): 175
Summary | Full Text: HTMLPDF 
 
  
  
 LCZ-696.
Angiotensin AT1 receptor antagonist/neprilysin inhibitor, Treatment of heart failure, Treatment of hypertension.
Chrysant, S.G.
Drugs Fut 2011, 36(3): 183
Summary | Full Text: HTMLPDF 
 
  
  
 Vemurafenib.
B-raf kinase inhibitor, Oncolytic.
Puzanov, I., Flaherty, K.T., Sosman, J.A., Grippo, J.F., Su, F., Nolop, K., Lee, R.J., Bollag, G.
Drugs Fut 2011, 36(3): 191
Summary | Full Text: HTMLPDF 
 
  
 
REVIEW ARTICLES
 
  
 Future perspectives of epigenetic drugs in oral cancer.
Vogliatzi, P., Claudio, P.P.
Drugs Fut 2011, 36(3): 201
Summary | Full Text: HTMLPDF 
 
  
  
 Hearing loss: What's in the pipeline?
Chen, G., Lobarinas, E., Ding, D., Salvi, R.
Drugs Fut 2011, 36(3): 209
Summary | Full Text: HTMLPDF 
 
  
  
 Progress in the delivery of siRNA therapeutics: potential in uveal melanoma.
Gollob, J.A., Bumcrot, D., Toudjarska, I., Bastian, B.C., Sah, D.W., Vaishnav, A.K.
Drugs Fut 2011, 36(3): 229
Summary | Full Text: HTMLPDF 
 
  
 
TARGETS TO WATCH
 
  
 Targeting HSP 27 for the treatment of castration-resistant prostate cancer.
Zoubeidi, A., Chi, K.N., Gleave, M.
Drugs Fut 2011, 36(3): 241
Summary | Full Text: HTMLPDF 
 
  
 
MEETING REPORT
 
  
 Kinase inhibitors from early research to clinic: highlights of the Society for Medicines Research Symposium, held on June 24, 2010, at AstraZeneca, Alderley Park Conference Centre, Alderley Park, Macclesfield, UK.
Allen, J., Collingwood, S.P., Ratcliffe, A.J.
Drugs Fut 2011, 36(3): 249
Summary | Full Text: HTMLPDF 
 
  
 
  



© 2020 Clarivate Analytics. All rights reserved.
Copyright NoticeTerms of UsePrivacy StatementCookie Policy